- Home
- LCTX vs MBCN Comparison
LCTX vs MBCN Comparison
Compare LCTX & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- MBCN
- Stock Information
- Founded
- LCTX 1990
- MBCN 1901
- Country
- LCTX United States
- MBCN United States
- Employees
- LCTX N/A
- MBCN N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- MBCN Major Banks
- Sector
- LCTX Health Care
- MBCN Finance
- Exchange
- LCTX Nasdaq
- MBCN Nasdaq
- Market Cap
- LCTX 274.0M
- MBCN 231.2M
- IPO Year
- LCTX N/A
- MBCN N/A
- Fundamental
- Price
- LCTX $1.84
- MBCN $32.92
- Analyst Decision
- LCTX Strong Buy
- MBCN Hold
- Analyst Count
- LCTX 4
- MBCN 1
- Target Price
- LCTX $4.25
- MBCN $35.00
- AVG Volume (30 Days)
- LCTX 1.7M
- MBCN 21.5K
- Earning Date
- LCTX 11-13-2025
- MBCN 10-22-2025
- Dividend Yield
- LCTX N/A
- MBCN 2.47%
- EPS Growth
- LCTX N/A
- MBCN 48.42
- EPS
- LCTX N/A
- MBCN 2.61
- Revenue
- LCTX $10,914,000.00
- MBCN $75,400,000.00
- Revenue This Year
- LCTX N/A
- MBCN $18.85
- Revenue Next Year
- LCTX $176.00
- MBCN $6.69
- P/E Ratio
- LCTX N/A
- MBCN $12.43
- Revenue Growth
- LCTX 76.43
- MBCN 16.60
- 52 Week Low
- LCTX $0.37
- MBCN $22.74
- 52 Week High
- LCTX $1.85
- MBCN $34.68
- Technical
- Relative Strength Index (RSI)
- LCTX 53.70
- MBCN 57.54
- Support Level
- LCTX $1.66
- MBCN $33.22
- Resistance Level
- LCTX $1.79
- MBCN $34.68
- Average True Range (ATR)
- LCTX 0.10
- MBCN 0.89
- MACD
- LCTX -0.02
- MBCN 0.51
- Stochastic Oscillator
- LCTX 46.87
- MBCN 69.92
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About MBCN Middlefield Banc Corp.
Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.